throbber
Savings and Support
`
`Join the Best Face Forward Program for treatment tips, tools, and special offers.
`*
`Most members pay no more than $25 for a 30-day supply of ORACEA. Sign up today.
`
`Already signed up?
`I’m already signed up but I don’t have a Care Card.
`
`
`
`GET CARD
`
`Sign up
`In order to register you have to sign up either for "Best Face Forward Program" or "ORACEA Care Card"
` NO
`
`
`YES
`
`I want skin care tips, diet and lifestyle advice, treatment
`information, news, and money-saving offers from the Best
`Face Forward Program and Galderma
`
`1
`
`

`

`YES
`
` NO
`
`
`
`I want the ORACEA Care Card so I may pay no more
`than $25* each time I refill (30-day supply)
`
`All fields are required
`
`ZIP CODE
`
`EMAIL
`
`CONFIRM EMAIL
`
`YES
`
` NO
`
`
`
`I've filled my ORACEA prescription more than 2 times
`
`SUBMIT
`
`Galderma is committed to protecting and safeguarding your privacy. To better understand how we use the data
`you provide from this site, please read our Privacy Policy. We will not sell your information, and you will not
`receive anything from us that you have not agreed to receive.
`
`Important Safety Information

`Indication: ORACEA (doxycycline, USP) is indicated for the treatment of only inflammatory lesions (papules and pustules) of
`rosacea in adult patients. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in

`patients treated with ORACEA were nasopharyngitis, sinusitis, diarrhea, hypertension and aspartate aminotransferase


`increase. Warnings/Precautions: ORACEA should not be used to treat or prevent infections. ORACEA should not be taken

`by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA should not be taken during
`pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years). Although photosensitivity was not

`observed in clinical trials, ORACEA patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of

`ORACEA treatment beyond 16 weeks and safety beyond 9 months have not been established.
`
`You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-
`FDA-1088.
`
`*For insured patients only. Certain limitations apply. Click here for program details.
`
`2
`
`

`

` Site Map
` About Galderma
` Contact Us
` Legal
` Prescribing Information
` Privacy
`For Healthcare Professionals
`© 2014 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for
`U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.
`
`3
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket